Building research capacity for treating cryptococcal meningitis in AIDS patients
Genomic Research Capacity Building for Cryptococcosis Translational Studies
This study is working to find better treatments for cryptococcal meningitis, a serious infection that affects people with AIDS, by helping African researchers explore new ways to fight the infection and boost the immune system, ultimately aiming to save lives and improve health outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10896934 on NIH RePORTER |
What this research studies
This research focuses on improving treatment strategies for cryptococcal meningitis (CM), a severe infection that significantly affects individuals with AIDS. The project aims to enhance the ability of African researchers to conduct basic and translational studies in genomics and immunology related to CM. By addressing both the fungal virulence and the host immune response, the research seeks to develop novel therapies that can reduce mortality and improve patient outcomes. The collaboration involves multiple universities in Africa and aims to strengthen local research capabilities.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are living with AIDS and are at risk for or currently suffering from cryptococcal meningitis.
Not a fit: Patients who are not affected by AIDS or cryptococcal meningitis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that significantly lower mortality rates and improve the quality of life for patients suffering from cryptococcal meningitis.
How similar studies have performed: Previous research has shown success in improving treatment outcomes for cryptococcal meningitis through collaborative studies, indicating that this approach has potential for impactful results.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Nielsen, Kirsten — University of Minnesota
- Study coordinator: Nielsen, Kirsten
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.